Healthcare Technology Leaders Saved Time and Money by Accelerating Innovation Using Rhapsody Health Solutions BOSTON , Aug. 27, 2024 /PRNewswire/ -- Rhapsody, a global leader in digital health enablement and interoperability, today announced the results of a 2024 Forrester Consulting Total Economic ImpactTM (TEI) study. The study reveals a significant 193% return on investment (ROI) over three years for interviewed health technology teams using Rhapsody integration solutions, offering an efficient and compliant approach to healthcare data integration.
The TEI study displays how the healthcare specialized solutions from Rhapsody meet the complex needs of healthcare technology organizations, including managing intricate data standards like FHIR, HL7, and DICOM, while ensuring compliance with global data privacy regulations. Unlike broad cross-industry platforms, the Rhapsody healthcare-specific approach enables faster, more scalable growth with fewer resources. Key findings from the study are conveyed through the lens of a composite healthcare technology organization with $25M in annual recurring revenue, representative of interviewed Rhapsody customers.
In addition to a 193% ROI, the study found a net present value of $1.59 million over three years, with a payback period of less than six months, plus: $1M in avoided costs (per $25M ARR) over three years due to streamlined staffing and reduced need for new hires. 30 days faster time to market per customer onboarded, leading to .